Cargando…

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Shapiro, Michael D., Fazio, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315180/ https://www.ncbi.nlm.nih.gov/pubmed/32614936 http://dx.doi.org/10.1016/j.jacbts.2020.04.010

Ejemplares similares

Lipoprotein (a): A Frustrating Final Frontier in Lipid Management?
por: Libby, Peter
Publicado: (2016)

Megalin/lipoprotein receptor-related protein 2 autoimmunity and kidney disease
por: Perez-Gomez, Maria V, et al.
Publicado: (2020)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
por: Vavlukis, Marija
Publicado: (2017)

Lipoprotein(a): A Taxi for Autotaxin Takes a Toll in Calcific Aortic Valve Disease
por: Towler, Dwight A.
Publicado: (2017)

Relationship Between Low‐Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab
por: Shapiro, Michael D., et al.
Publicado: (2019)

COVID-19 herd immunity by immunisation: are children in the herd?
por: Obaro, Stephen
Publicado: (2021)

Monte Carlo simulations to meet the ESC recommended low-density lipoprotein cholesterol targets
por: Deo, Salil V.
Publicado: (2023)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Lipids and Lipoproteins in Health and Disease
por: Bezsonov, Evgeny E., et al.
Publicado: (2021)

COVID-19 herd immunity: where are we?
por: Fontanet, Arnaud, et al.
Publicado: (2020)

Is Non-High-Density Lipoprotein Cholesterol Evaluation Perfect? From the High-Density Lipoprotein Function Viewpoint
por: Otsuka, Toshiaki
Publicado: (2022)

Herd immunity: hyperimmune globulins for the 21st century
por: Elliott, Sarah TC, et al.
Publicado: (2018)

Herd immunity or health equity? – extending HPV vaccination
por: Keddy, Karen H., et al.
Publicado: (2023)

New Perspectives on Cholesterol and Lipoprotein Metabolism
por: De Geest, Bart, et al.
Publicado: (2023)

Lipoprotein(a) Removal Still a Mystery
por: Nestel, Paul
Publicado: (2019)

Comment on Aaseth et al. Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy. Nutrients 2022, 14, 2381
por: Paredes, Sílvia, et al.
Publicado: (2022)

SARS-CoV-2: from herd immunity to hybrid immunity
por: Goldblatt, David
Publicado: (2022)

Re‐examining the high‐density lipoprotein hypothesis
por: Tan, Kathryn
Publicado: (2016)

High-Density Lipoproteins in Non-Cardiovascular Diseases
por: Zanotti, Ilaria
Publicado: (2022)

Lipoprotein (a): A Novel Cardiovascular Risk Factor
por: Kozarova, Miriam, et al.
Publicado: (2023)

Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough?
por: Chenet, Stella M, et al.
Publicado: (2021)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

The enigmatic COVID-19 pandemic
por: Bhatia, Rajesh, et al.
Publicado: (2020)

PCSK9 Inhibition: Does Lipoprotein Size Matter?
por: Si‐Tayeb, Karim, et al.
Publicado: (2015)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Residual Risk Still Remains in Low-Density Lipoprotein
por: Hirano, Tsutomu
Publicado: (2022)

Rapamycin in lipoproteins for enhanced delivery
por: Cho, Kyung-Hyun
Publicado: (2012)

High-density lipoprotein: does it have a dark side?
por: Von Feldt, Joan M
Publicado: (2008)

Lipoprotein (a): Recent Updates on a Unique Lipoprotein
por: Saeed, Anum, et al.
Publicado: (2021)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

The Long and Winding Road: To the Proper Understanding of High-density Lipoprotein
por: Sung, Jidong
Publicado: (2020)

Lipoproteins and β-Cell Functions: From Basic to Clinical Data
por: Lee, Dae Ho
Publicado: (2014)

Modulation of High-Density Lipoprotein Function via Cardiac Rehabilitation
por: Satomi-Kobayashi, Seimi, et al.
Publicado: (2018)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
por: Julve, Josep, et al.
Publicado: (2021)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
por: Julve, Josep, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t4jtqmt96bt7dac7bk9io958af